Skandinaviska Enskilda Banken (SEB)
MRNA icon

Skandinaviska Enskilda Banken (SEB)’s Moderna MRNA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-517
Closed -$13.3K – 786
2025
Q3 		$13.3K Sell
517
-485
-48% -$13.5K ﹤0.01% 768
2025
Q2 		$27.6K Sell
1,002
-65,453
-98% -$1.72M ﹤0.01% 814
2025
Q1 		$1.88M Hold
66,455
– – 0.01% 582
2024
Q4 		$2.62M Sell
66,455
-13,348
-17% -$638K 0.01% 527
2024
Q3 		$5.33M Sell
79,803
-165,884
-68% -$15.2M 0.02% 393
2024
Q2 		$29.1M Buy
245,687
+706
+0.3% +$89.3K 0.14% 122
2024
Q1 		$26.1M Buy
244,981
+736
+0.3% +$74.2K 0.13% 147
2023
Q4 		$24.3M Sell
244,245
-7,567
-3% -$636K 0.14% 140
2023
Q3 		$26M Sell
251,812
-52,345
-17% -$5.84M 0.17% 116
2023
Q2 		$37M Sell
304,157
-3,693
-1% -$493K 0.24% 88
2023
Q1 		$47.3M Buy
307,850
+59,310
+24% +$9.78M 0.33% 64
2022
Q4 		$44.6M Sell
248,540
-47,284
-16% -$7.73M 0.34% 74
2022
Q3 		$35M Buy
295,824
+25,128
+9% +$3.81M 0.27% 83
2022
Q2 		$38.7M Buy
270,696
+88,737
+49% +$12.7M 0.28% 75
2022
Q1 		$31.3M Sell
181,959
-29,788
-14% -$5.01M 0.18% 107
2021
Q4 		$53.3M Sell
211,747
-31,856
-13% -$9.31M 0.27% 77
2021
Q3 		$93.8M Buy
243,603
+103,910
+74% +$38.3M 0.51% 40
2021
Q2 		$32.8M Buy
139,693
+27,122
+24% +$4.85M 0.2% 110
2021
Q1 		$14.7M Sell
112,571
-21,602
-16% -$3.13M 0.1% 205
2020
Q4 		$14M Buy
134,173
+940
+0.7% +$95.1K 0.1% 195
2020
Q3 		$9.43M Buy
133,233
+14,496
+12% +$1.01M 0.07% 241
2020
Q2 		$7.63M Buy
118,737
+118,387
+33,825% +$6.48M 0.06% 261
2020
Q1 		$10K Buy
+350
New +$8.05K ﹤0.01% 902

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s MRNA Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Moderna (MRNA) in Q4 2025, closing a stake of 517 shares — an estimated $13.3K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MRNA in Q1 2020 and held it in 23 quarters. The position peaked at $93.8M in Q3 2021. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 517 Moderna shares in Q4 2025, an estimated $13.3K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Moderna in Q1 2020 and held it in 23 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Moderna position peaked at $93.8M in Q3 2021.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.